(FE)
With the number of coronavirus cases crossing the 4 lakh-mark, India is now ranked fourth after United States, Brazil and Russia in the list of worst-affected countries by the COVID-19 disease. According to WHO, Sunday witnessed the highest-ever single day spike in cases. Worldwide, more than 183,000 new cases in the latest 24 hours. As per the health ministry’s latest data on Monday, 445 deaths and spike of 14,821 new COVID-19 positive cases were reported in India in last 24 hours. Coronavirus positive cases in India stand at 4,25,282 including 1,74,387 active cases, 2,37,196 cured/discharged/migrated. The death toll is 13,699, the ministry said. However, there is one silver lining that the recovery rate from the disease has now touched 55%. Maharashtra, Delhi, Tamil Nadu, Gujarat and Uttar Pradesh are among the states reporting most number of coronavirus cases in India.
Meanwhile, in what could be seen as a big achievement in the fight against the global pandemic, Indian pharmaceutical company Glenmark has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of Coronavirus. The Mumbai headquartered company said the medicine, which is priced at Rs 103 per tablet, can be used to treat mild to moderate COVID-19 cases.
